Weiliang Zhu

机构：Fudan University, Zhujiang Hospital, Huashan Hospital, Southern Medical University · ORCID：0000-0002-1024-4389

发表论文 128 篇 · 总被引 1891 次 · h-index 24

代表论文

• ARTEMIS-001: Data from a phase 1a/b study of HS-20093 in patients with relapsed small cell lung cancer (SCLC). (2024 · Journal of Clinical Oncology · 被引 24)
• Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation (2024 · Advanced Science · 被引 22)
• Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS) (2024 · Frontiers in Pharmacology · 被引 13)
• Targeting PFKFB4 Biomimetic Codelivery System Synergistically Enhances Ferroptosis to Suppress Small Cell Lung Cancer and Augments the Efficacy of Anti‐PD‐L1 Immunotherapy (2025 · Advanced Science · 被引 12)
• Synthesis of Natural Product‐like Indeno[2,1‐ b ]indole/Shikimic Acid Hybrid Analogues with Anti‐osteoclastogenic Activity via Photo‐Nazarov Reaction (2024 · European Journal of Organic Chemistry · 被引 1)
• Ciliogenesis-associated Kinase 1 Promotes Breast Cancer Cell Proliferation and Chemoresistance via Phosphorylating ERK1 (2024 · International Journal of Biological Sciences · 被引 1)